Cited by

  1. N. G. Iyer, Ashok R. Shaha, Carl E. Silver, Kenneth O. Devaney, Alessandra Rinaldo, Phillip K. Pellitteri, Alfio Ferlito. 2010. Thyroid incidentalomas: to treat or not to treat. European Archives of Oto-Rhino-Laryngology 267:7, 1019-1026. [CrossRef]
  2. M. Hermann, K. Tonninger, F. Kober, E.-M. Furtlehner, A. Schultheis, N. Neuhold. 2010. Minimal-invasives follikuläres Schilddrüsenkarzinom. Der Chirurg . [CrossRef]
  3. Cüneyd Anil , Sibel Goksel , Alptekin Gursoy . 2010. Hashimoto's Thyroiditis Is Not Associated with Increased Risk of Thyroid Cancer in Patients with Thyroid Nodules: A Single-Center Prospective StudyHashimoto's Thyroiditis Is Not Associated with Increased Risk of Thyroid Cancer in Patients with Thyroid Nodules: A Single-Center Prospective Study. Thyroid 20:6, 601-606. [Abstract] [Full Text] [PDF] [PDF Plus]
  4. Elizabete R. Miranda , Eduardo L. Padrão , Barbara C. Silva , Luiz De Marco , Marta S. Sarquis . 2010. Papillary Thyroid Carcinoma with Brain Metastases: An Unusual 10-Year-Survival CasePapillary Thyroid Carcinoma with Brain Metastases: An Unusual 10-Year-Survival Case. Thyroid 20:6, 657-661. [Abstract] [Full Text] [PDF] [PDF Plus]
  5. Joanna Klubo-Gwiezdzinska , Douglas Van Nostrand , Kenneth D. Burman , Vasyl Vasko , Stanley Chia , Tom Deng , Kanchan Kulkarni , Leonard Wartofsky . 2010. Salivary Gland Malignancy and Radioiodine Therapy for Thyroid CancerSalivary Gland Malignancy and Radioiodine Therapy for Thyroid Cancer. Thyroid 20:6, 647-651. [Abstract] [Full Text] [PDF] [PDF Plus]
  6. 2010. CorrectionCorrection. Thyroid 20:6, 674-675. [Citation] [Full Text] [PDF] [PDF Plus]
  7. Michael Wehmeier , Thorsten Petrich , Korbinian Brand , Ralf Lichtinghagen , Eric Hesse . 2010. Oncofetal Fibronectin mRNA Is Highly Abundant in the Blood of Patients with Papillary Thyroid Carcinoma and Correlates with High-Serum Thyroid-Stimulating Hormone LevelsOncofetal Fibronectin mRNA Is Highly Abundant in the Blood of Patients with Papillary Thyroid Carcinoma and Correlates with High-Serum Thyroid-Stimulating Hormone Levels. Thyroid 20:6, 607-613. [Abstract] [Full Text] [PDF] [PDF Plus]
  8. Carole Spencer , Shireen Fatemi , Peter Singer , John Nicoloff , Jonathan LoPresti . 2010. Serum Basal Thyroglobulin Measured by a Second-Generation Assay Correlates with the Recombinant Human Thyrotropin–Stimulated Thyroglobulin Response in Patients Treated for Differentiated Thyroid CancerSerum Basal Thyroglobulin Measured by a Second-Generation Assay Correlates with the Recombinant Human Thyrotropin–Stimulated Thyroglobulin Response in Patients Treated for Differentiated Thyroid Cancer. Thyroid 20:6, 587-595. [Abstract] [Full Text] [PDF] [PDF Plus]
  9. Anastasios Gkountouvas , Ifigeneia Kostoglou-Athanassiou , Eirini Veniou , Panagiotis Repousis , Nikolaos Ziras , Philippos Kaldrimidis . 2010. Hematologic Toxicity in Patients Treated with Sunitinib for Advanced Thyroid CancerHematologic Toxicity in Patients Treated with Sunitinib for Advanced Thyroid Cancer. Thyroid 20:6, 597-600. [Abstract] [Full Text] [PDF] [PDF Plus]
  10. Ian D. Hay. 2010. Managing Patients with a Preoperative Diagnosis of AJCC/UICC Stage I (T1N0M0) Papillary Thyroid Carcinoma: East Versus West, Whose Policy is Best?. World Journal of Surgery 34:6, 1291-1293. [CrossRef]
  11. Babita Panigrahi, Sanziana A. Roman, Julie Ann Sosa. 2010. Medullary Thyroid Cancer: Are Practice Patterns in the United States Discordant From American Thyroid Association Guidelines?. Annals of Surgical Oncology 17:6, 1490-1498. [CrossRef]
  12. Marcin Barczyński, Aleksander Konturek, Alicja Hubalewska-Dydejczyk, Filip Gołkowski, Stanisław Cichoń, Wojciech Nowak. 2010. Five-year Follow-up of a Randomized Clinical Trial of Total Thyroidectomy versus Dunhill Operation versus Bilateral Subtotal Thyroidectomy for Multinodular Nontoxic Goiter. World Journal of Surgery 34:6, 1203-1213. [CrossRef]
  13. Jordi L. Reverter, Eulàlia Colomé, Susana Holgado, Eva Aguilera, Berta Soldevila, Lourdes Mateo, Anna Sanmartí. 2010. Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma. Endocrine 37:3, 467-472. [CrossRef]
  14. Jandee Lee, Kuk Young Nah, Ra Mi Kim, Yeun Hee Ahn, Euy-Young Soh, Woong Youn Chung. 2010. Differences in postoperative outcomes, function, and cosmesis: open versus robotic thyroidectomy. Surgical Endoscopy . [CrossRef]
  15. Gregory W. Randolph . 2010. The Importance of Pre- and Postoperative Laryngeal Examination for Thyroid SurgeryThe Importance of Pre- and Postoperative Laryngeal Examination for Thyroid Surgery. Thyroid 20:5, 453-458. [Citation] [Full Text] [PDF] [PDF Plus]
  16. Omer Turker , Ismail Dogan , Kamil Kumanlioglu . 2010. Radioiodine Accumulation in a Large Adnexal CystadenofibromaRadioiodine Accumulation in a Large Adnexal Cystadenofibroma. Thyroid 20:5, 561-562. [Abstract] [Full Text] [PDF] [PDF Plus]
  17. Gui-Zhou Xiao. 2010. Central Lymph Node Metastasis as a Predictor of Lateral Node Involvement in Papillary Thyroid Carcinoma: Reply to Letter. World Journal of Surgery . [CrossRef]
  18. Fabian Pitoia , Laura S. Ward . 2010. Differences Between Latin American and American Associations' Thyroid Cancer GuidelinesDifferences Between Latin American and American Associations' Thyroid Cancer Guidelines. Thyroid 20:4, 361-362. [Citation] [Full Text] [PDF] [PDF Plus]
  19. Clodagh S. O'Gorman , Jill Hamilton , Marianna Rachmiel , Abha Gupta , Bo Ye Ngan , Denis Daneman . 2010. Thyroid Cancer in Childhood: A Retrospective Review of Childhood CourseThyroid Cancer in Childhood: A Retrospective Review of Childhood Course. Thyroid 20:4, 375-380. [Abstract] [Full Text] [PDF] [PDF Plus]
  20. David S. Cooper . 2010. Response to Pitoia and WardResponse to Pitoia and Ward. Thyroid 20:4, 362-362. [Citation] [Full Text] [PDF] [PDF Plus]
  21. John H. Yim , Sally E. Carty . 2010. Thyroid Surgery and Surgeons: The Common Interest. Thyroid 20:4, 357-358. [Citation] [Full Text] [PDF] [PDF Plus]
  22. Kristien Boelaert. 2010. Thyroid gland: Revised guidelines for the management of thyroid cancer. Nature Reviews Endocrinology 6:4, 185-186. [CrossRef]
  23. L. J. Layfield, E. S. Cibas, Z. Baloch. 2010. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium. Cytopathology 21:2, 75-85. [CrossRef]
  24. P. V. Pradeep, S. Kuldeep. 2010. Central Lymph Node Metastasis: Is It a Reliable Indicator of Node Involvement in Papillary Thyroid Carcinoma? Letter to the Editor. World Journal of Surgery. [CrossRef]
  25. R. Michael Tuttle , Norma Lopez , Rebecca Leboeuf , Shaye M. Minkowitz , Ravinder Grewal , Matvey Brokhin , Gal Omry , Steve Larson . 2010. Radioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy FunctionRadioactive Iodine Administered for Thyroid Remnant Ablation Following Recombinant Human Thyroid Stimulating Hormone Preparation Also Has an Important Adjuvant Therapy Function. Thyroid 20:3, 257-263. [Abstract] [Full Text] [PDF] [PDF Plus]
  26. Elizabeth N. Pearce , Alex Stagnaro-Green . 2010. Hypothyroidism in Pregnancy: Do Guidelines Alter Practice?Hypothyroidism in Pregnancy: Do Guidelines Alter Practice?. Thyroid 20:3, 241-242. [Citation] [Full Text] [PDF] [PDF Plus]
  27. Bernadette Biondi , David S. Cooper . 2010. Benefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid CancerBenefits of Thyrotropin Suppression Versus the Risks of Adverse Effects in Differentiated Thyroid Cancer. Thyroid 20:2, 135-146. [Abstract] [Full Text] [PDF] [PDF Plus]
  28. John C. Morris . 2010. Resveratrol, Thyroid Cancer, and Iodide: Drink Up?Resveratrol, Thyroid Cancer, and Iodide: Drink Up?. Thyroid 20:2, 125-126. [Citation] [Full Text] [PDF] [PDF Plus]
  29. Ralf Paschke, Kurt Werner Schmid, Roland Gärtner, Klaus Mann, Henning Dralle, Christian Reiners. 2010. Epidemiologie, Pathophysiologie, leitliniengerechte Diagnostik und Therapie des Schilddrüsenknotens. Medizinische Klinik 105:2, 80-87. [CrossRef]
  30. Carrie C. Lubitz , William C. Faquin , Jingyun Yang , Michal Mekel , Randall D. Gaz , Sareh Parangi , Gregory W. Randolph , Richard A. Hodin , Antonia E. Stephen . 2010. Clinical and Cytological Features Predictive of Malignancy in Thyroid Follicular Neoplasms Clinical and Cytological Features Predictive of Malignancy in Thyroid Follicular Neoplasms. Thyroid 20:1, 25-31. [Abstract] [Full Text] [PDF] [PDF Plus] [Supplementary material]
  31. Kyung Tae Park, Soon-Hyun Ahn, Ji-Hun Mo, Young Joo Park, Do Joong Park, Sang Il Choi, So-Yeon Park. 2010. Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules. Head & Neck n/a-n/a. [CrossRef]
  32. Nam Seop Lee, Ja Seong Bae, So-Ryeong Jeong, Chan Kwon Jung, Dong Jun Lim, Woo Chan Park, Jeong Soo Kim, Seung Nam Kim. 2010. Risk Factors of Lymph Node Metastasis in Papillary Thyroid Microcarcinoma. Journal of the Korean Surgical Society 78:2, 82. [CrossRef]
  33. Jung Jin Cho. 2010. Screening of Thyroid Cancer and Management of Thyroid Incidentaloma. Korean Journal of Family Medicine 31:2, 87. [CrossRef]
  34. Angelo Carpi, Jeffrey I. Mechanick, Sven Saussez, Andrea Nicolini. 2010. Thyroid tumor marker genomics and proteomics: Diagnostic and clinical implications. Journal of Cellular Physiology n/a-n/a. [CrossRef]
  35. Jennifer A. Sipos . 2009. Advances in Ultrasound for the Diagnosis and Management of Thyroid CancerAdvances in Ultrasound for the Diagnosis and Management of Thyroid Cancer. Thyroid 19:12, 1363-1372. [Abstract] [Full Text] [PDF] [PDF Plus]
  36. Marina N. Nikiforova , Yuri E. Nikiforov . 2009. Molecular Diagnostics and Predictors in Thyroid CancerMolecular Diagnostics and Predictors in Thyroid Cancer. Thyroid 19:12, 1351-1361. [Abstract] [Full Text] [PDF] [PDF Plus]
  37. Martin Schlumberger , Steven I. Sherman . 2009. Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances. Thyroid 19:12, 1393-1400. [Abstract] [Full Text] [PDF] [PDF Plus]
  38. Douglas Van Nostrand . 2009. The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid CancerThe Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer. Thyroid 19:12, 1381-1391. [Abstract] [Full Text] [PDF] [PDF Plus]
  39. Rebecca S. Sippel , Herbert Chen . 2009. Controversies in the Surgical Management of Newly Diagnosed and Recurrent/Residual Thyroid CancerControversies in the Surgical Management of Newly Diagnosed and Recurrent/Residual Thyroid Cancer. Thyroid 19:12, 1373-1380. [Abstract] [Full Text] [PDF] [PDF Plus]
  40. Caroline S. Kim , Xuguang Zhu . 2009. Lessons from Mouse Models of Thyroid CancerLessons from Mouse Models of Thyroid Cancer. Thyroid 19:12, 1317-1331. [Abstract] [Full Text] [PDF] [PDF Plus]
  41. Charles H. Emerson . 2009. Guidelines for Guidelines: Content, Accountability, Peer Review, and Intellectual Ownership Guidelines for Guidelines: Content, Accountability, Peer Review, and Intellectual Ownership. Thyroid 19:11, 1137-1138. [Citation] [Full Text] [PDF] [PDF Plus]
  42. Leonard Wartofsky . 2009. Highlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 RevisionHighlights of the American Thyroid Association Guidelines for Patients with Thyroid Nodules or Differentiated Thyroid Carcinoma: The 2009 Revision. Thyroid 19:11, 1139-1143. [Citation] [Full Text] [PDF] [PDF Plus]
  43. Efisio Puxeddu , Sebastiano Filetti . 2009. The 2009 American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer: Progress on the Road from Consensus- to Evidence-Based PracticeThe 2009 American Thyroid Association Guidelines for Management of Thyroid Nodules and Differentiated Thyroid Cancer: Progress on the Road from Consensus- to Evidence-Based Practice. Thyroid 19:11, 1145-1147. [Citation] [Full Text] [PDF] [PDF Plus]
  44. Sally E. Carty , David S. Cooper , Gerard M. Doherty , Quan-Yang Duh , Richard T. Kloos , Susan J. Mandel , Gregory W. Randolph , Brendan C. Stack , Jr. , David L. Steward , David J. Terris , Geoffrey B. Thompson , Ralph P. Tufano , R. Michael Tuttle , Robert Udelsman . 2009. Consensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid CancerThe American Thyroid Association Surgery Working Group with Participation from the American Association of Endocrine Surgeons, American Academy of Otolaryngology—Head and Neck Surgery, and American Head and Neck SocietyConsensus Statement on the Terminology and Classification of Central Neck Dissection for Thyroid Cancer. Thyroid 19:11, 1153-1158. [Abstract] [Full Text] [PDF] [PDF Plus]
  45. Martha A. Zeiger. 2009. Evolution in the surgical management of well-differentiated thyroid cancer or not: To dissect or not dissect the central lymph node compartment. Journal of Surgical Oncology n/a-n/a. [CrossRef]